HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18)

Clinical trials for HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18) explained in plain language.

Never miss a new study

Get alerted when new HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18) trials appear

Sign up with your email to follow new studies for HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Daily supplements tested as shield against colds and infections

Prevention Ongoing

This study is checking if taking daily vitamin D or fish oil (omega-3) supplements can help prevent common infections in generally healthy adults. It involves over 25,000 people who are already part of a larger health study. Researchers will track how often participants get sick …

Matched conditions: HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18)

Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Prevention

Last updated Mar 18, 2026 14:41 UTC

HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18)

Get alerted when new HUMAN CATHELICIDIN ANTIMICROBIAL PEPTIDE (HCAP-18) trials appear

Daily supplements tested as shield against colds and infections